Gilead Sciences Inc (GILD)
67.08
+0.05
(+0.07%)
USD |
NASDAQ |
Apr 24, 16:00
67.29
+0.21
(+0.31%)
After-Hours: 20:00
Gilead Sciences Accounts Payable (Quarterly): 550.00M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 550.00M |
September 30, 2023 | 586.00M |
June 30, 2023 | 622.00M |
March 31, 2023 | 627.00M |
December 31, 2022 | 905.00M |
September 30, 2022 | 614.00M |
June 30, 2022 | 565.00M |
March 31, 2022 | 583.00M |
December 31, 2021 | 705.00M |
September 30, 2021 | 585.00M |
June 30, 2021 | 608.00M |
March 31, 2021 | 570.00M |
December 31, 2020 | 844.00M |
September 30, 2020 | 527.00M |
June 30, 2020 | 532.00M |
March 31, 2020 | 590.00M |
December 31, 2019 | 713.00M |
September 30, 2019 | 632.00M |
June 30, 2019 | 617.00M |
March 31, 2019 | 577.00M |
December 31, 2018 | 790.00M |
September 30, 2018 | 580.00M |
June 30, 2018 | 623.00M |
March 31, 2018 | 711.00M |
December 31, 2017 | 814.00M |
Date | Value |
---|---|
September 30, 2017 | 696.00M |
June 30, 2017 | 819.00M |
March 31, 2017 | 944.00M |
December 31, 2016 | 1.206B |
September 30, 2016 | 1.052B |
June 30, 2016 | 1.122B |
March 31, 2016 | 945.00M |
December 31, 2015 | 1.178B |
September 30, 2015 | 1.239B |
June 30, 2015 | 1.571B |
March 31, 2015 | 1.011B |
December 31, 2014 | 955.00M |
September 30, 2014 | 1.183B |
June 30, 2014 | 1.162B |
March 31, 2014 | 1.235B |
December 31, 2013 | 1.256B |
September 30, 2013 | 1.350B |
June 30, 2013 | 1.391B |
March 31, 2013 | 1.356B |
December 31, 2012 | 1.327B |
September 30, 2012 | 1.320B |
June 30, 2012 | 1.367B |
March 31, 2012 | 1.339B |
December 31, 2011 | 1.206B |
September 30, 2011 | 1.064B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
527.00M
Minimum
Sep 2020
905.00M
Maximum
Dec 2022
630.26M
Average
608.00M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Amgen Inc | 1.59B |
Johnson & Johnson | 9.632B |
Eli Lilly and Co | 2.599B |
Pfizer Inc | 6.71B |
CymaBay Therapeutics Inc (DELISTED) | 3.828M |